Fig. 2From: Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney diseaseUltra-performance liquid chromatography-mass spectrometry pattern of Bupi Yishen formulaBack to article page